Novo Nordisk, a Danish company, announced on Thursday that it would expand its production facilities in Chartres, France, with an investment of about 16 billion crowns, or $2.34 billion.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.